USD 14.81
(2.99%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 669.76 Million USD | 11.98% |
2022 | 598.11 Million USD | 10.6% |
2021 | 540.79 Million USD | 37.36% |
2020 | 393.71 Million USD | 6.28% |
2019 | 370.46 Million USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 188.22 Million USD | -5.89% |
2024 Q1 | 200 Million USD | 23.57% |
2023 Q4 | 161.85 Million USD | -4.71% |
2023 Q3 | 169.84 Million USD | 2.26% |
2023 Q2 | 166.09 Million USD | -3.42% |
2023 Q1 | 171.96 Million USD | 17.39% |
2023 FY | 669.76 Million USD | 11.98% |
2022 Q3 | 148.77 Million USD | -0.57% |
2022 Q2 | 149.62 Million USD | -2.35% |
2022 Q1 | 153.21 Million USD | 15.3% |
2022 FY | 598.11 Million USD | 10.6% |
2022 Q4 | 146.49 Million USD | -1.54% |
2021 Q4 | 132.89 Million USD | -3.26% |
2021 FY | 540.79 Million USD | 37.36% |
2021 Q3 | 137.37 Million USD | 4.42% |
2021 Q2 | 131.56 Million USD | -5.33% |
2021 Q1 | 138.97 Million USD | 23.16% |
2020 Q4 | 112.83 Million USD | 8.4% |
2020 Q3 | 104.09 Million USD | 17.76% |
2020 Q1 | 88.39 Million USD | 0.0% |
2020 Q2 | 88.39 Million USD | 0.0% |
2020 FY | 393.71 Million USD | 6.28% |
2019 FY | 370.46 Million USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Alcon Inc. | 10.09 Billion USD | 93.363% |
AptarGroup, Inc. | 3.48 Billion USD | 80.795% |
Baxter International Inc. | 14.81 Billion USD | 95.479% |
Becton, Dickinson and Company | 20.17 Billion USD | 96.681% |
Bausch + Lomb Corporation | 4.14 Billion USD | 83.846% |
Haemonetics Corporation | 1.3 Billion USD | 48.836% |
Envista Holdings Corp | 2.56 Billion USD | 73.904% |
ResMed Inc. | 4.68 Billion USD | 85.705% |
Teleflex Incorporated | 2.97 Billion USD | 77.483% |
West Pharmaceutical Services, Inc. | 2.94 Billion USD | 77.295% |